Physician
Bonuel-Silverio, Maria
Bonuel-Silverio, Maria was paid $3.54M by Medicaid between Feb 2018 and Dec 2024, across 63 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 36% of everything it billed.
33Billing provider infoBONUEL-SILVERIO, MARIA
BROWNSVILLE, TX 78520
BROWNSVILLE, TX 78520
33aNPI1639138357assigned 03/21/2006
33bProvider typePediatrics Physician
28Total paid$3.54M
24GClaims165,180
24DCodes billed63
24AFirst – last monthFeb 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Texas
Rank by total paid#132 of 1,136
Median peer was paid$329K
This provider vs. median11×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 182 | $5K | |
| 2019 | 172 | $4K | |
| 2020 | 7,212 | $132K | |
| 2021 | 42,903 | $922K | |
| 2022 | 42,824 | $935K | |
| 2023 | 39,904 | $841K | |
| 2024incomplete | 31,983 | $705K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 36% | 35,014 | 26,665 | $1.29M |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 8.5% | 7,170 | 6,500 | $301K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 7.2% | 10,365 | 9,146 | $254K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.9% | 2,945 | 2,940 | $245K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 6.6% | 2,650 | 2,645 | $233K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.8% | 2,599 | 2,585 | $204K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 5.1% | 13,423 | 6,251 | $181K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 4.7% | 14,982 | 8,202 | $166K |
| S8301 | Infection control supplies, not otherwise specified | 4.4% | 5,440 | 4,656 | $157K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.2% | 1,934 | 1,849 | $147K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 4.1% | 10,738 | 10,095 | $146K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.5% | 8,010 | 7,042 | $51K |
51 more codes
| 87428 | 1.2% | 588 | $42K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 4,346 | $34K |
| 87807 | <1% | 2,864 | $31K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,516 | $14K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 878 | $10K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 106 | $9K |
| 0071A | <1% | 185 | $7K | |
| 0072A | <1% | 174 | $7K | |
| 90461 | <1% | 1,246 | $6K | |
| 81002 | <1% | 1,506 | $4K | |
| 96160 | <1% | 896 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 744 | $1K |
| 0081A | <1% | 34 | $1K | |
| 97169 | <1% | 26 | $970.40 | |
| 99050 | <1% | 101 | $806.76 | |
| 0082A | <1% | 18 | $720.00 | |
| 99051 | <1% | 38 | $552.78 | |
| 85027 | <1% | 51 | $266.07 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 15 | $214.65 |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | <1% | 43 | $173.16 |
| 80061 | Lipid panel | <1% | 13 | $146.25 |
| 90686 | <1% | 2,807 | $43.37 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 5,244 | $40.32 |
| 90677 | <1% | 357 | $0.14 | |
| 90621 | <1% | 507 | $0.02 | |
| 3725F | 0% | 3,018 | $0.00 | |
| 90670 | 0% | 1,161 | $0.00 | |
| 90710 | 0% | 541 | $0.00 | |
| 90633 | 0% | 590 | $0.00 | |
| 90734 | 0% | 620 | $0.00 | |
| 90655 | 0% | 177 | $0.00 | |
| 91308 | 0% | 88 | $0.00 | |
| 90685 | 0% | 117 | $0.00 | |
| 99173 | 0% | 13 | $0.00 | |
| 90672 | 0% | 55 | $0.00 | |
| 90700 | 0% | 37 | $0.00 | |
| 90715 | 0% | 92 | $0.00 | |
| 90658 | 0% | 25 | $0.00 | |
| 90647 | 0% | 572 | $0.00 | |
| 91307 | 0% | 443 | $0.00 | |
| 90696 | 0% | 63 | $0.00 | |
| 3008F | 0% | 7,193 | $0.00 | |
| 2001F | 0% | 7,190 | $0.00 | |
| 90651 | 0% | 810 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 688 | $0.00 |
| 90698 | 0% | 459 | $0.00 | |
| 90680 | 0% | 943 | $0.00 | |
| 97802 | 0% | 577 | $0.00 | |
| 90723 | 0% | 65 | $0.00 | |
| 90660 | 0% | 44 | $0.00 | |
| 90744 | 0% | 26 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.